Lois Lutz

Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

Peter J. Houghton, Pamela J. Cheshire, James D. Hallman et al. · Cancer Chemotherapy and Pharmacology · 1995 · 407 citations

Medicine, Oncology, Pharmacology +12

Efficacy of systemic administration of irinotecan against neuroblastoma xenografts.

Joyce Thompson, William C. Zamboni, Pamela J. Cheshire et al. · PubMed · 1997 · 126 citations

Medicine, Oncology, Pharmacology +9

Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.

Janet A. Houghton, Pamela J. Cheshire, James D. Hallman et al. · PubMed · 1996 · 45 citations

Medicine, Oncology, Pharmacology +10

Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors

Peter J. Houghton, Pamela J. Cheshire, James D. Hallman et al. · Cancer Chemotherapy and Pharmacology · 1995 · 20 citations

Medicine, Oncology, Pharmacology +12

Efficacy of sulofenur and a second generation diarylsulfonylurea, N-[5-(2,3-dihydrobenzofuryl) sulfonyl]-N'-(3,4-dichlorophenyl)urea (LY295501), against colon adenocarcinoma xenografts

Peter J. Houghton, Pamela J. Cheshire, Leann Myers et al. · Anti-Cancer Drugs · 1995 · 10 citations

Medicine, Oncology, Pharmacology +6